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The notion of educating the public through generic healthy eating messages has pervaded
dietary health promotion efforts over the years and continues to do so through various
media, despite little evidence for any enduring impact upon eating behaviour. There is grow-
ing evidence, however, that tailored interventions such as those that could be delivered
online can be effective in bringing about healthy dietary behaviour change. The present
paper brings together evidence from qualitative and quantitative studies that have con-
sidered the public perspective of genomics, nutrigenomics and personalised nutrition, includ-
ing those conducted as part of the EU-funded Food4Me project. Such studies have
consistently indicated that although the public hold positive views about nutrigenomics
and personalised nutrition, they have reservations about the service providers’ ability to en-
sure the secure handling of health data. Technological innovation has driven the concept of
personalised nutrition forward and now a further technological leap is required to ensure the
privacy of online service delivery systems and to protect data gathered in the process of
designing personalised nutrition therapies.
Personalised nutrition: Nutrigenomics: Beneﬁt: Risk: Information technology: Food4Me
What is personalised nutrition?
Internet and mobile phone technology has become inte-
gral to our daily activities and health and eating behav-
iour is no exception with recent technical advances
having fuelled a drive towards direct-to-consumer
(D-T-C) personalised nutrition. Personalised nutrition
is an innovative concept that seeks to identify individual
nutritional needs based on health status, genotype(1) and/
or phenotype(2) and then to provide healthy eating advice
that is tailored to suit the individual (Food4me.org).
Meanwhile, there is a growing body of evidence for the
effectiveness of tailored feedback in bringing about
healthy behaviour change(3–6). Surveys of D-T-C services
have suggested that they are effective in producing
healthy behaviour change in approximately one-third
of users(7–10). Awareness of D-T-C genetic tests is increas-
ing among consumers(11). Those with a stake-hold in the
delivery of personalised nutrition see immense potential
to transform preventative and therapeutic nutrition and
in doing so, to beneﬁt public health and reduce health
costs(12). Personalised nutrition not only has potential
for the tailoring of diet to individual health needs, but
also to that of groups of people among the general pub-
lic(13). For personalised nutrition intervention to have
any real and enduring impact upon public health,
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however, we need to understand and take into account
the public vision for such services(14). Early D-T-C perso-
nalised nutrition initiatives have, on the whole, not been
commercially successful. Despite the recent rapid ad-
vance in interactive health technology(12) and the poten-
tial for societal beneﬁt, there is a dearth of research in the
area of personalised nutrition and nutrigenomics from
the perspective of the general public(15,16). Much of
what research exists has focused on genetic testing albeit
in various contexts, while fewer studies have considered
personalised nutrition in particular.
What do the public think about nutrigenomics?
The future success of personalised nutrition in practice
will depend upon the public being ready and able to
take up aspects of the technology that are essential to ser-
vice delivery. Personalised medicine and personalised nu-
trition share certain technologies. Genetic proﬁling is
common to personalised medicine and nutrition and is
likely to be important (along with phenotype, etc.) in
informing personalised nutrition initiatives in the future.
Understanding attitudes towards genetic testing, there-
fore, is relevant to understanding public response to
nutrigenomics which represents the more ‘medicalised’
level of personalised nutrition provision.
Qualitative enquiry into societal views on genetic test-
ing undertaken in the USA(17–23), Australia(24),
Switzerland(25), the Netherlands(26) and the UK(27),
has indicated that people are aware of the potential ben-
eﬁts and hold generally positive attitudes towards genetic
testing. Potential drivers of the uptake of genetic testing
include own health(17,18,24,28,29), the health of other fam-
ily members and descendants(17–19,24), for research pur-
poses(17,24,30) and curiosity(10,18,24,25,28,30,31). All these
studies, however, also catalogued concerns surrounding
the enabling technology. Online privacy and the poten-
tial for information to be used by companies for com-
mercial gain or to fall into the hands of insurers,
employers or government agencies are among issues
that have been consistently raised(17–27,32,33). Aspects of
the service delivery system itself may also need to be per-
sonalised. Whereas some studies of factors determining
uptake of genetic testing(23,34), have suggested that consu-
mers liked the notion of autonomy and being in con-
trol(33), other works have implied that some consumers
would prefer the input of a health professional(32,35,36).
In view of the differing perspectives, the mode of service
delivery may need to be personalised.
Survey studies conducted in the USA(8,37–47),
Canada(48), Russia(49,50), Finland(51,52), Sweden(53), the
Netherlands(54), Australia(55), Canada(56) and the
UK(57) have indicated largely positive attitudes towards
genetic testing. The public also appear positive about
donating genetic material to biobanks(19,58,59) and willing
to supply genetic material for research purposes(60).
Reasons suggested by the public for taking up genetic
testing not only include improving one’s own
health(61–64), but also of other family members and des-
cendants(62–66) . Unsurprisingly, therefore, those with a
family history of inherited conditions have been found
to have more favourable attitudes towards genetic test-
ing(21,55,67) and may be willing to pay more(56). A sizeable
proportion would avail of genetic testing for no reason
other than curiosity(42,49,50,61,62,68). Others, on the other
hand, may not want to know test results unless treatment
was available(53,54).
Despite generally positive attitudes towards genetic
testing, and in keeping with existing qualitative studies
into genetic testing (see previous paragraph), quantitative
research, mainly surveys conducted over the last
couple of decades conducted in the USA(8,37,68–71),
Canada(48,56), Australia(72), Europe(73), the UK(59),
Finland(74,75) and the Netherlands(76) also indicate
considerable concern among the public about internet
privacy, data security, data use and data des-
tiny(41,43,44,51–56). Previous surveys into public attitudes
towards genomics(52,53,55,67), however, have failed to re-
cruit samples that have been representative of the general
population, making it difﬁcult to draw ﬁrm conclusions
as to the response of various societal groups to this
emerging technology. Attitudes to genetic testing, how-
ever, appear to vary by gender, age and educational
level. Males(8,52,57,63) and older individuals(11,37,52,57)
appear most favourable towards the notion of genetic
testing. Analyses of the impact of education level upon atti-
tudes towards genetic testing have produced mixed
results(11,21,40,46,77–79). Those educated to a higher edu-
cational level(21,78) and those in minority ethnic groups(43,44)
appear particularly concerned over data protection, use and
destiny.
What does the public think about personalised nutrition?
Whereas personalised medicine relates genotypic infor-
mation to propensity for disease, personalised nutrition
relates genotypic information to optimal diet and
health(80). Personalised nutrition also differs from nutri-
genomics in taking a broader view of health and dietary
health promotion and considering not only genotype, but
also phenotype and lifestyle. This could render persona-
lised nutrition less ethically sensitive and more amenable
to public health promotion. However, consumer re-
sponse to nutrigenomics and personalised nutrition re-
mains an under researched area. Only a handful of
qualitative (Morin(81)) and survey(82,83) studies have con-
sidered the public perspective of nutrigenomics, all of
which have indicated that between one-third and a one-
half of those surveyed would be willing to avail such ser-
vices and to follow a tailored diet. Having a health prob-
lem was also associated with being positive about
receiving genetic-proﬁling information for the purpose
of personalising their diet(82,83). Research conducted in
the Netherlands has indicated that consumers may be
more amenable towards web-based personalised nu-
trition if they were in control of the use of the results(84).
In keeping with this notion, other studies have implied
that doubts about data security, data use and destiny
would deter use of such services(82,83).






















The EU-funded Food4Me project appears to be the ﬁrst
of its kind to have adopted a mixed, qualitative and
quantitative, survey design to gain an understanding of
what would determine or deter uptake and compliance
with personalised nutrition among the European general
public and to establish the best way to deliver such
services.
Focus group discussions were held in each of eight
European countries (Spain, the UK, Ireland, the
Netherlands, Poland, Portugal, Greece and Germany)
during early 2012. Discussion was prompted using sce-
narios that depicted personalised nutrition at three suc-
cessive levels of ‘medicalisation’ for which lifestyle,
phenotypic and genetic information was collected
(Food4me.org). The concept of personalised nutrition
was viewed positively with potential to enhance health.
Discourses arising in all eight countries framed persona-
lised nutrition in terms of perceived beneﬁt and risk(85).
The sort of beneﬁt expected from personalised nutrition
were health related and similar to those which have
been previously reported(61–64) and included those related
to health and ﬁtness such as losing weight, building mus-
cle, preventing and treating disease. D-T-C personalised
nutrition services were likened to ‘the food equivalent
of a personal trainer’. Themes otherwise centred on the
online delivery technology. The convenience of accessing
dietary health services in the comfort of one’s own home
directly and not having to involve the general prac-
titioner were also considered advantageous. The poten-
tial for anonymity afforded by such a system could
serve to spare embarrassment and enable greater honesty
in reporting dietary health behaviour.
Perceived risks were unrelated to personalised nu-
trition per se but rather to aspects of the delivery system
itself such as those incurred by unwittingly visiting spuri-
ous websites or as a consequence of a lack of online
security. Although in favour of personalised nutrition,
the European public were unanimous across eight
countries in expressing negative views on the ability of
web-based enabling technology to ensure privacy and
overcome issues surrounding data protection, usage and
data destiny(85). As has been found in previous quali-
tative studies of genetic testing(17–27,32,33) and nutrige-
nomics(82), issues surrounding data mishandling arose
with concerns expressed about where information could
end up. Possibilities discussed included the potential for
commercial exploitation, for example, the selling of
data to advertisers or spammers, as well as the more sin-
ister possibility of surveillance purposes by insurers,
employers and government agencies.
The next stage in the research process was to deter-
mine the distribution and generalisability of these ideas
quantitatively. The prior qualitative research ﬁndings
were used to inform the selection of items and validated
scales and for inclusion in the Food4Me survey. The re-
sultant questionnaire was translated and back-translated
into the native languages of each of the nine EU coun-
tries (Germany, Greece, Ireland, Poland, Portugal,
Spain, the Netherlands, the UK and Norway) involved
in the study. Members of the European public (n 9381)
were quota sampled to be nationally representative for
each country, on sex, age and education level and then sur-
veyed online during February andMarch 2013. Similar to
the previous surveys of public opinion of genetic test-
ing(41,43,44,51–56), the Food4Me survey found that per-
ceived beneﬁt was associated with intention to take up
personalised nutrition. Statistical modelling suggested
that the beneﬁt attributed to personalised nutrition con-
tributed to more favourable attitude towards and inten-
tion to adopt personalised nutrition(86). Perceived beneﬁt
was also associated with less perceived risk. Perceived
risk was unrelated to intention to take up personalised nu-
trition. A possible explanation for this ﬁnding, and one
suggested by the prior qualitative research, is that risk
was not actually related to the concept of personalised nu-
trition but to the online delivery technology.
The Food4Me results, therefore, agree with those of
previous studies that have investigated attitudes to gen-
etic testing in suggesting that the public are acutely
aware of the threat for data mishandling and misuse.
Together, the qualitative and survey results suggest that
to encourage uptake of personalised nutrition and enable
people to achieve healthy dietary change, we must em-
phasise beneﬁts while making the delivery system secure.
Participants taking part in the initial qualitative studies
were able to make suggestions as to how to minimise
the damage should a privacy or data-handling mishap
occur, for example, storing demographic, lifestyle and
biological data separately. Nevertheless, the issue of
how to ensure online privacy and protect and control
data usage and destiny remains.
What does the future hold for personalised nutrition?
Previous research ﬁndings provide some clues as to why
despite evidence that tailored interventions are effective
in bringing about healthy behaviour change, early
attempts to deliver personalised nutrition services on a
commercial scale have failed. Expectancy value theories
allow us to consider the implications of these ﬁndings
for behaviour change. Protection motivation theory(87–89)
holds that the likelihood of a behaviour occurring, for
example, taking up personalised nutrition, will depend
upon the perceived size, severity and likelihood of any
associated risk and perceived ability to reduce the risk.
This implies a need for further consumer research to es-
tablish the perceived size, severity and likelihood of risk
associated with online D-T-C personalised nutrition as
well as perceived ability to reduce the risk and interaction
with perceived beneﬁt.
The overarching message from the research into the
public response to genetic testing, nutrigenomics and per-
sonalised nutrition is that for D-T-C personalised nu-
trition to be taken up on a societal scale, people will
need assurances that all online interactions would be pri-
vate and that the provider will have ability to effectively
handle and protect information collected in the endeav-
our to design personalised diets. In the wake of accidents





















resulting in public data falling into the ‘wrong’ hands and
recent revelations about how data generated through
social media and other personal internet activities is
used for marketing purposes and commercial gain, per-
ceived weaknesses inherent in such technology are likely
to limit the future development, consumer uptake and
growth of such services.
Potential consumers, although positive about the con-
cept of personalised nutrition, are telling us that in order
for them to take up such services the information col-
lected will require regulation(90). Control of the handling
and use of health-related data will only be effective if the
technology is in place to enable compliance with regu-
lation(91). Interdisciplinary research and innovation is
needed urgently to render the delivery of health systems
such as personalised nutrition secure and enable this po-
tentially important public health innovation. Delivering
personalised nutrition to the public will require working
closely with information technologists in getting the de-
livery system perfected. Technological innovation has
driven the concept of D-T-C health systems. The future
of personalised nutrition would also appear to lie in the
hands of information technologists. Meanwhile, pro-
motion of personalised nutrition to the general public
would do well to emphasise the (personal) beneﬁts of per-
sonalised nutrition.
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